Keywords: roche, wins, tamiflu, prevention, use, usa, hoffmann-la

Roche wins Tamiflu prevention use in USA

Article | 21 November 2000

Hoffmann-La Roche has won US Food and Drug Administration approval tomarket its oral neuraminidase inhibitor Tamiflu (oseltamivir) for the prevention ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Go to company listing

Related Drugs

Oseltamivir Phosphate

Tamiflu

Relenza

Zanamivir

Nystatin

Go to drug listing